Braskem SA

BAK · B3

$1.70+$0.10 (+6.25%)TodayMarket closed ·
Prev close $1.60

About BAK

Braskem SA engages in the manufacture of petrochemicals and other related products. The company is headquartered in Camacari, Bahia. The firm operates in the first and second generations of the petrochemical industry and its activities are divided into three operational segments: Brazil; the United States and Europe; and Mexico. The Brazil segment is focused on the production of polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC) and caustic soda, among others. The United States and Europe segment is responsible for the production, operations, and sales of polypropylene in the United States and Germany. The Mexico segment comprises production, operation, and sale of ethylene, high-density polyethylene (HDPE), and low-density polyethylene (LDPE).

Employees
8,233
Headquarters
Camacari, Bahia
Listed
Dec 18, 1978
Sector
Materials
Industry
Chemicals

BAK key statistics

Market cap
3.19B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.93M
Volume
1.07M
Open price
$1.59
High today
$1.72
Low today
$1.59
52 Week high
$5.40
52 Week low
$1.40

Braskem SA (BAK) at a glance

As of Oct 23, 2026, Braskem SA (BAK) shares are priced at $1.70, giving the company a market cap of 3.19B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.59 and $1.72. The current price is 7.3% above the day's low and 1.2% below its high.

Volume so far is 1.07M shares, below the average of 1.93M shares a day.

Over the past year Braskem SA has ranged from $1.40 to $5.40, and now sits 8% of the way up that range.

Braskem SA met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $4.17 per share against an estimate of $1.60.

The average analyst price target is $3.20, 88.3% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 4 analyst ratings say Buy
  • Buy0.0%
  • Hold50.0%
  • Sell50.0%
Price target · 10 analystsAvg $3.20
Low
$1.53
Now
$1.70
High
$5.95

BAK earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 252.9% on average.

  1. Q3 FY24: reported -$0.75 per share against an estimate of $0.2112
  2. Q4 FY24: reported -$7.08 per share against an estimate of -$0.7292
  3. Q1 FY25: reported $0.88 per share against an estimate of $0.4642
  4. Q2 FY25: reported -$0.39 per share against an estimate of -$1.10
  5. Q3 FY25: reported -$0.06 per share against an estimate of -$1.13
  6. Q4 FY25: reported -$12.82 per share against an estimate of -$2.62
  7. Q1 FY26: reported $1.81 per share against an estimate of -$0.2395
  8. Q2 FY26: reported $4.17 per share against an estimate of $1.60

BAK news

  • Avi Kapoor

    Crude Oil Down Over 3%; US Business Inventories Surge In July

  • Avi Kapoor

    Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releaseBusiness Wire

    Lallemand Biofuels & Distilled Spirits and Braskem Announce Bio-Acetone as a Coproduction Opportunity in Ethanol Facilities

  • Press releaseBusiness Wire

    Braskem’s Commitment to Safety Recognized with Six Texas Chemistry Council (TCC) Awards

  • Press releaseBusiness Wire

    Blooming Future Launches Operations as Part of Braskem's Expanding Sustainable Fleet

  • 'Braskem Idesa, Creditors Near Deal for Bankruptcy Loan' - Bloomberg

  • Press releaseBusiness Wire

    Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Braskem S.A. - BAK

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.